Patent foramen ovale post-surgical follow up

Patent Foramen Ovale Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Patent Foramen Ovale from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis PFO and Stroke
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X-ray
Echocardiography and Ultrasound
CT
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Interventions
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Patent foramen ovale post-surgical follow up On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Patent foramen ovale post-surgical follow up All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Patent foramen ovale post-surgical follow up
CDC on Patent foramen ovale post-surgical follow up
Patent foramen ovale post-surgical follow up in the news
Blogs on Patent foramen ovale post-surgical follow up
Directions to Hospitals Treating Patent foramen ovale
Risk calculators and risk factors for Patent foramen ovale post-surgical follow up

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editors-In-Chief: Priyamvada Singh, M.B.B.S. [2]; Assistant Editor-In-Chief: Kristin Feeney, B.S. [3]

Overview

Aspirin or warfarin should be continued for 6 months after percutaneous closure of patent foramen ovale

See also

• Atrioventricular septal defect
• Congenital heart disease
• Atrial septal defect

Template:WikiDoc Sources